2017
DOI: 10.1016/j.ebiom.2017.07.018
|View full text |Cite
|
Sign up to set email alerts
|

The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells

Abstract: Acute myeloid leukemia (AML) is a severe and often fatal systemic malignancy. Malignant cells are capable of escaping host immune surveillance by inactivating cytotoxic lymphoid cells. In this work we discovered a fundamental molecular pathway, which includes ligand-dependent activation of ectopically expressed latrophilin 1 and possibly other G-protein coupled receptors leading to increased translation and exocytosis of the immune receptor Tim-3 and its ligand galectin-9. This occurs in a protein kinase C and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
161
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 173 publications
(168 citation statements)
references
References 48 publications
7
161
0
Order By: Relevance
“…However, interesting results regarding the function of LPHN1 in the etiopathogenesis of AML were published in 2017. Ectopically expressed LPHN1 in AML cells may secure their capability to escape the immune system by inactivating cytotoxic lymphoid cells via the ligand-dependent activation of latrophilin-1 and possibly other G-protein coupled receptors leading to increased translation and exocytosis of the immune receptor Tim-3 and its ligand galectin-9 (Goncalves Silva et al 2017).…”
Section: Resultsmentioning
confidence: 99%
“…However, interesting results regarding the function of LPHN1 in the etiopathogenesis of AML were published in 2017. Ectopically expressed LPHN1 in AML cells may secure their capability to escape the immune system by inactivating cytotoxic lymphoid cells via the ligand-dependent activation of latrophilin-1 and possibly other G-protein coupled receptors leading to increased translation and exocytosis of the immune receptor Tim-3 and its ligand galectin-9 (Goncalves Silva et al 2017).…”
Section: Resultsmentioning
confidence: 99%
“…78 Furthermore, increased serum levels of Galectin-9 and Tim-3 were observed in the plasma of patients with acute myeloid leukemia and chronic lymphocytic leukemia, turning Galectin-9 into a potential target in leukemia. [79][80][81] Galectin-1 functioning is involved in many signaling pathways leading to anti-inflammatory activities by targeting multiple types of immune cells. 68 In T cells, it is controlling T cell effector function homeostasis by regulating activation, differentiation, survival and cytokine production.…”
Section: Galectinsmentioning
confidence: 99%
“…HAVCR2 was reported to be abnormally expressed in T-cell lymphoma, acute myeloid leukemia, hepatitis A and injured nerve tissue. It regulated the activity of target immune cells through NF-κB signaling pathway, mTOR signaling pathway and RET signaling pathway (Prokhorov et al, 2015;Goncalves Silva et al, 2017;Avery et al, 2018). The role of HAVCR2 in nerve injury was shown in patients with spontaneous intracerebral hemorrhage whose increased HAVCR2 expression on CD14+ monocytes was associated with systemic inflammatory response and sub-acute brain injury (Xu et al, 2018).…”
Section: Figure 9 |mentioning
confidence: 99%